Thuja occidentalis: An Unexplored Phytomedicine with Therapeutic Applications
- PMID: 35260050
- DOI: 10.2174/1386207325666220308153732
Thuja occidentalis: An Unexplored Phytomedicine with Therapeutic Applications
Abstract
Background: The recent outbreak of SARS-CoV-2 has received global attention. Due to a lack of recommended treatment regimens, the world faced various limitations resulting in improper management of the disease. Phytomedicines have played a prominent role in the prevention of various epidemics and pandemics in the past.
Objective: Here, we attempt to focus on safe and feasible use of Thuja occidentalis to manage and alleviate the panic of viral respiratory infections, including COVID-19, by strengthening an individual's immunity. The relevant information was collected from the web-based databases PubMed, Google Scholar, and MEDLINE, as well as other internet sources to review the applicability of T. occidentalis as a phytomedicine in managing respiratory infections and strengthening immunity.
Conclusion: As important phytomedicine, and antipsychotic, T. occidentalis possesses a plethora of immunological properties that can be used effectively in the management of viral respiratory infections and has the potential to prevent further progression of the disease. Importantly, this could be only a part of the approach for treatment during the current outbreak that should be considered along with other measures.
Keywords: COVID-19; Phytomedicine; Thuja occidentalis; antiviral; immunity; immunomodulatory; upper respiratory infection.
Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.
Similar articles
-
Unlocking the mechanistic potential of Thuja occidentalis for managing diabetic neuropathy and nephropathy.J Tradit Complement Med. 2024 Apr 24;14(6):581-597. doi: 10.1016/j.jtcme.2024.04.009. eCollection 2024 Nov. J Tradit Complement Med. 2024. PMID: 39850604 Free PMC article. Review.
-
COVID-19: a conundrum to decipher.Eur Rev Med Pharmacol Sci. 2020 May;24(10):5830-5841. doi: 10.26355/eurrev_202005_21378. Eur Rev Med Pharmacol Sci. 2020. PMID: 32495923
-
Pathogenesis-directed therapy of 2019 novel coronavirus disease.J Med Virol. 2021 Mar;93(3):1320-1342. doi: 10.1002/jmv.26610. Epub 2020 Nov 10. J Med Virol. 2021. PMID: 33073355 Review.
-
Thuja occidentalis L. and its active compound, α-thujone: Promising effects in the treatment of polycystic ovary syndrome without inducing osteoporosis.J Ethnopharmacol. 2015 Jun 20;168:25-30. doi: 10.1016/j.jep.2015.03.029. Epub 2015 Mar 27. J Ethnopharmacol. 2015. PMID: 25818694
-
Thuja occidentalis L. (Cupressaceae): Ethnobotany, Phytochemistry and Biological Activity.Molecules. 2020 Nov 19;25(22):5416. doi: 10.3390/molecules25225416. Molecules. 2020. PMID: 33228192 Free PMC article. Review.
Cited by
-
Kaempferol: A Review of Current Evidence of Its Antiviral Potential.Int J Mol Sci. 2023 Nov 14;24(22):16299. doi: 10.3390/ijms242216299. Int J Mol Sci. 2023. PMID: 38003488 Free PMC article. Review.
References
-
- Hui D.S.; Azhar I.; E.; Madani, T.A.; Ntoumi, F.; Kock, R.; Dar, O.; Ippolito, G.; Mchugh, T.D.; Memish, Z.A.; Drosten, C.; Zumla, A.; Petersen, E. The continuing 2019-nCoV epi-demic threat of novel coronaviruses to global health - The lat-est 2019 novel coronavirus outbreak in Wuhan, China. Int J Infect Dis 2020,91,264-266 - DOI - PubMed
-
- WHO coronavirus (COVID-19) dashboard | WHO coronavirus (COVID-19) Dashboard with vaccination data. Available from: (Accessed: August 30, 2021).
-
- Clinical Management Protocol for COVID19. Available from: (Accessed: June 27, 2020).
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous